Clinical Trial Update: Infliximab Infusion Rates in Pediatric Inflammatory Bowel Disease [NA]

View source ↗

Summary

This clinical trial update indicates that a study evaluating infliximab infusion rates in pediatric inflammatory bowel disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: University Hospital, Akershus | Conditions: Infliximab, Infusion | NA | Status: RECRUITING